Skip to main content

Peer Review reports

From: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure

Original Submission
22 May 2021 Submitted Original manuscript
5 Jun 2021 Reviewed Reviewer Report
23 Jun 2021 Reviewed Reviewer Report
13 Sep 2021 Author responded Author comments - Soo Kun Lim
18 Sep 2021 Author responded Author comments - Soo Kun Lim
Resubmission - Version 2
13 Sep 2021 Submitted Manuscript version 2
Publishing
3 Nov 2021 Editorially accepted
25 Nov 2021 Article published 10.1186/s12882-021-02601-w

You can find further information about peer review here.

Back to article page